On May 22, 2025, the DOL, HHS, and Treasury announced important initiatives to enhance and enforce existing healthcare price transparency requirements, particularly with respect to prescription drugs. The release follows President Trump’s February 25, 2025, executive order 14221, which called for rapid action to improve and fully implement health plan and hospital price transparency rules.
Employers – as group health plan sponsors – should be aware of these developments, which may bring additio